Neurological manifestation of cancer – paraneoplastic syndromes

1. Vogrig A, Gigli GL, Segatti S, Corazza E, Marini A, Bernardini A, et al. Epidemiology of paraneoplastic neurological syndromes: a population-based study. J Neurol. 2020;267(1):26-35.10.1007/s00415-019-09544-131552550 Search in Google Scholar

2. Hébert J, Riche B, Vogrig, A, Muñiz-Castrillo S, Joubert B, Picard G, et al. Epidemiology of paraneoplastic neurologic syndromes and autoimmune encephalitides in France. Neurol Neuroimmunol Neuroinflam. 2020;7:E883.10.1212/NXI.0000000000000883745531532847939 Search in Google Scholar

3. Ejma M. Paraneoplastic neurological syndromes. Family Med Primary Care Rev. 2012;14: 447-52. Search in Google Scholar

4. Graus F, Dalmau J. Paraneoplastic neurological syndromes. Curr Opin Neurol. 2012;25:795-801.10.1097/WCO.0b013e328359da15370517923041955 Search in Google Scholar

5. Molina-Garrido MJ, Guillén-Ponce C, Martínez S, Guirado-Risueño M. Diagnosis and current treatment of neurological paraneoplastic syndromes. Clin Transl Oncol. 2006;8(11):796-801.10.1007/s12094-006-0134-517134967 Search in Google Scholar

6. Liapi A, Herrera Gómez R, Sakeliades E, Sariwalaza I. EP974 Review of three cases of high grade serous ovarian cancer associated with cerebellar atrophy and acute inflammatory demyelinating polyneuropathy. IJGC. 2019;29:A516-A517.10.1136/ijgc-2019-ESGO.1020 Search in Google Scholar

7. Altabakhi IW, Babiker HM. Paraneoplastic Limbic Encephalitis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020. Available from: https://www.ncbi.nlm.nih.gov/books/NBK519523/ Search in Google Scholar

8. Vogrig A, Gigli GL, Segatti S, Corazza E, Marini A, Bernardini A, et al. Epidemiology of paraneoplastic neurological syndromes: a population-based study. J Neurol. 2020;267(1):26-35.10.1007/s00415-019-09544-1 Search in Google Scholar

9. Honnorat J, Viaccoz A. New concepts in paraneoplastic neurological syndromes. Rev Neurol. 2011;167:729-36.10.1016/j.neurol.2011.08.00121890156 Search in Google Scholar

10. Gozzard P, Maddison P. Which antibody and which cancer in which paraneoplastic syndromes? Pract Neurol. 2010;10:260-270. Search in Google Scholar

11. Williams JP, Carlson NG, Greenlee JE. Antibodies in autoimmune human neurological disease: Pathogenesis and immunopathology. Semin Neurol. 2018;38(3):267-77.10.1055/s-0038-166050130011408 Search in Google Scholar

12. Devine MF, Kothapalli N, Elkhooly M, Dubey D. Paraneoplastic neurological syndromes: clinical presentations and management. Ther Adv Neurol Disord. 2020;14:1-19. Search in Google Scholar

13. Liblau R, Benyahia B, Delattre JY. The pathophysiology of paraneoplastic neurological syndromes. Ann Med Interne. 1998;149(8):512-520. Search in Google Scholar

14. Miao S, Liao S, Li H, Niu B, Hu H, Qian Y, et al. Retrospective study of paraneoplastic neurological syndromes in a Chinese Han population from Shandong, East China. Int J Neurosci. 2018;128(9):821-7.10.1080/00207454.2018.143069329355452 Search in Google Scholar

15. van Coevorden-Hameete MH, van Beuningen SFB, Perrenoud M, Will L, Hulsenboom E, Demonet J, et al. Antibodies to TRIM46 are associated with paraneoplastic neurological syndromes. Ann Clin Transl Neurol. 2017;4(9):680-6.10.1002/acn3.396559054728904989 Search in Google Scholar

16. Kwiatkowski S, Kolasińska K, Knap B, Przystupski D, Kotowski K, Bartosik W, et al. An overview of paraneoplastic neurological syndromes–pathophysiolog y and clinical insight. WSN. 2018,108:87-98. Search in Google Scholar

17. Honnorat J. Onconeural antibodies are essential to diagnose paraneoplastic neurological syndromes. Acta Neurol Scand Suppl. 2006;183:64-8.10.1111/j.1600-0404.2006.00620.x16637934 Search in Google Scholar

18. Alexopoulos H, Dalakas MC. The immunobiology of autoimmune encephalitides. J Autoimmun. 2019;104:102339.10.1016/j.jaut.2019.10233931611142 Search in Google Scholar

19. Vernino S. Paraneoplastic cerebellar degeneration. Handb Clin Neurol. 2012;103:215-23.10.1016/B978-0-444-51892-7.00013-921827891 Search in Google Scholar

20. Madhavan AA, Carr CM, Morris PP, Flanagan EP, Kotsenas AL, Hunt CH, et al. Imaging review of Paraneoplastic Neurologic Syndromes. AJNR. 2020;41(12):2176-87.10.3174/ajnr.A6815796326133093137 Search in Google Scholar

21. Sakai K. Paraneoplastic cerebellar degeneration. Brain Nerve. 2010;62(4):357-64. Search in Google Scholar

22. Newman MP, Blum S, Wong R, Scott J, Prain K, Wilson R, et al. Autoimmune encephalitis. Intern Med J. 2016;46(2):148-57.10.1111/imj.1297426899887 Search in Google Scholar

23. Shen K, Xu Y, Guan H, Zhong W, Chen M, Zhao J, Li L, Wang M. Paraneoplastic limbic encephalitis associated with lung cancer. Sci Rep. 2018;8(1):6792.10.1038/s41598-018-25294-y593155129717222 Search in Google Scholar

24. Budhram A, Leung A, Nicolle MW, Burneo JG. Diagnosing autoimmune limbic encephalitis. CMAJ. 2019;13;191(19):E529-E534.10.1503/cmaj.181548652006731085562 Search in Google Scholar

25. Liu CY, Zhu J, Zheng XY, Ma C, Wang X. Anti-N-methyl-D-aspartate receptor encephalitis: A severe, potentially reversible autoimmune encephalitis. Mediators Inflamm. 2017;2017:6361479.10.1155/2017/6361479549405928698711 Search in Google Scholar

26. Williams TJ, Benavides DR, Patrice KA, Dalmau JO, de Ávila AL, Le DT, et al. Association of autoimmune encephalitis with combined immune checkpoint inhibitor treatment for metastatic cancer. JAMA Neurol. 2016;73(8):928-33.10.1001/jamaneurol.2016.139927271951 Search in Google Scholar